FDA Inspection 675227 — GlaxoSmithKline LLC
The FDA completed an inspection of GlaxoSmithKline LLC on July 27, 2010 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 27, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Durham, NC (United States)
Additional Details
Sponsor, Contract Research Organization